世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

MRI造影剤の世界市場レポート、歴史と予測 2017-2028年


Global MRI Contrast Agents Market Report, History and Forecast 2017-2028

Market Analysis and Insights:MRI造影剤の世界市場 COVID-19のパンデミックにより、MRI造影剤の世界市場規模は2021年に1384.86百万米ドルと推定され、検討期間中のCAGRは5.87%で2028年までに2110.73百万米ドル... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年1月26日 US$3,350
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

Market Analysis and Insights:MRI造影剤の世界市場
COVID-19のパンデミックにより、MRI造影剤の世界市場規模は2021年に1384.86百万米ドルと推定され、検討期間中のCAGRは5.87%で2028年までに2110.73百万米ドルと再調整されると予測されています。
MRI造影剤の世界主要メーカーには、Bayer、Guerbet Group、Bracco Imaging、GE Healthcare、BeiLu Pharma、Hengrui Medicineなどがあります。2021年には、世界の大手6社が売上高ベースで約94.07%のシェアを占めています。
北米のMRI造影剤市場は、2021年に462.57百万米ドル、中国は2028年に489.74百万米ドルになると予測されています。中国の割合は2021年に17.77%で、2028年には23.20%に達し、分析期間中のCAGRは9.65%になると予測されています。ヨーロッパのMRI造影剤市場では、ドイツが2028年までに1億3,601万ドルに達すると予測されています。アジアでは、日本と韓国が注目されており、今後6年間のCAGRはそれぞれ4.68%と6.63%です。
ガドテレート・メグルミンは、2021年のMRI造影剤世界市場の27.37%を占めており、ポストCOVID-19の期間に5.49%のCAGRで成長し、2028年には5億6,317万米ドルになると予測されています。一方、病院セグメントは、この予測期間中に7.44%のCAGRで変化し、2028年には約85.00%のシェアを占めることになります。
世界のMRI造影剤の範囲と市場規模
MRI造影剤の世界市場は、地域(国)別、企業別、タイプ別、アプリケーション別に分類されています。世界のMRI造影剤市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント分析では、2017年から2028年までの地域(国)別、タイプ別、アプリケーション別の売上高、収益、予測に焦点を当てています。
企業別
バイエル
Guerbetグループ
ブラッコ・イメージング
GEヘルスケア
BeiLu Pharma
Hengrui Medicine

タイプ別セグメント
ガドブトロール
ガドテレートメグルミン
ガドベン酸ジメグルミン
ガドペンテートジメグルミン
ガドテリドール
ガドディアミン
その他

用途別セグメント
病院
クリニック

地域別
北アメリカ
アメリカ
カナダ

アジア太平洋
中国
日本
韓国
インド
台湾
東南アジア
オーストラリア

ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア

ラテンアメリカ
メキシコ
ブラジル
アルゼンチン

中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦

ページTOPに戻る


目次

1 MRI Contrast Agents Market Overview 1
1.1 MRI Contrast Agents Product Overview 1
1.2 MRI Contrast Agents Market Segment by Type 3
1.2.1 Gadobutrol 3
1.2.2 Gadoterate Meglumine 5
1.2.3 Gadobenate Dimeglumine 6
1.2.4 Gadopentetate Dimeglumine 7
1.2.5 Gadoteridol 8
1.2.6 Gadodiamine 9
1.2.7 Others 10
1.3 Global MRI Contrast Agents Market Size by Type 11
1.3.1 Global MRI Contrast Agents Market Size Overview by Type (2017-2028) 11
1.3.2 Global MRI Contrast Agents Historic Market Size Review by Type (2017-2022) 12
1.3.3 Global MRI Contrast Agents Forecasted Market Size by Type (2023-2028) 14
1.4 Key Regions Market Size Segment by Type 17
1.4.1 North America MRI Contrast Agents Sales Breakdown by Type (2017-2022) 17
1.4.2 Europe MRI Contrast Agents Sales Breakdown by Type (2017-2022) 18
1.4.3 Asia-Pacific MRI Contrast Agents Sales Breakdown by Type (2017-2022) 19
1.4.4 Latin America MRI Contrast Agents Sales Breakdown by Type (2017-2022) 20
1.4.5 Middle East and Africa MRI Contrast Agents Sales Breakdown by Type (2017-2022) 21
2 MRI Contrast Agents Market Competition by Company 22
2.1 Global Top Players by MRI Contrast Agents Sales (2019-2022) 22
2.2 Global Top Players by MRI Contrast Agents Revenue (2019-2022) 23
2.3 Global Top Players by MRI Contrast Agents Price (2019-2022) 24
2.4 Global Top Manufacturers MRI Contrast Agents Manufacturing Base Distribution, Sales Area 25
2.5 MRI Contrast Agents Market Competitive Situation and Trends 25
2.5.1 MRI Contrast Agents Market Concentration Rate (2019-2022) 25
2.5.2 Global 3 and 5 Largest Manufacturers by MRI Contrast Agents Revenue in 2021 26
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRI Contrast Agents as of 2021) 26
2.7 Established Date of Key MRI Contrast Agents Manufacturers 27
2.8 Key Manufacturers MRI Contrast Agents Product Offered 28
2.9 Mergers & Acquisitions, Expansion 28
3 MRI Contrast Agents Status and Outlook by Region 29
3.1 Global MRI Contrast Agents Market Size and CAGR by Region: 2017 VS 2021 VS 2028 29
3.2 Global MRI Contrast Agents Historic Market Size by Region 29
3.2.1 Global MRI Contrast Agents Sales in Volume by Region (2019-2022) 29
3.2.2 Global MRI Contrast Agents Sales in Value by Region (2017-2022) 30
3.2.3 Global MRI Contrast Agents Sales (Volume & Value), Price and Gross Margin (2017-2022) 31
3.3 Global MRI Contrast Agents Forecasted Market Size by Region 31
3.3.1 Global MRI Contrast Agents Sales in Volume by Region (2023-2028) 31
3.3.2 Global MRI Contrast Agents Sales in Value by Region (2023-2028) 32
3.3.3 Global MRI Contrast Agents Sales (Volume & Value), Price and Gross Margin (2023-2028) 32
4 MRI Contrast Agents by Application 33
4.1 MRI Contrast Agents Market Segment by Application 33
4.1.1 Hospitals 33
4.1.2 Clinics 34
4.2 Global MRI Contrast Agents Market Size by Application 35
4.2.1 Global MRI Contrast Agents Market Size Overview by Application (2017-2028) 35
4.2.2 Global MRI Contrast Agents Historic Market Size Review by Application (2017-2022) 36
4.2.3 Global MRI Contrast Agents Forecasted Market Size by Application (2023-2028) 37
4.3 Key Regions Market Size Segment by Application 37
4.3.1 North America MRI Contrast Agents Sales Breakdown by Application (2017-2022) 37
4.3.2 Europe MRI Contrast Agents Sales Breakdown by Application (2017-2022) 38
4.3.3 Asia-Pacific MRI Contrast Agents Sales Breakdown by Application (2017-2022) 39
4.3.4 Latin America MRI Contrast Agents Sales Breakdown by Application (2017-2022) 40
4.3.5 Middle East and Africa MRI Contrast Agents Sales Breakdown by Application (2017-2022) 41
5 North America MRI Contrast Agents by Country 43
5.1 North America MRI Contrast Agents Historic Market Size by Country 43
5.1.1 North America MRI Contrast Agents Sales in Volume by Country (2017-2022) 43
5.1.2 North America MRI Contrast Agents Sales in Value by Country (2017-2022) 43
5.2 North America MRI Contrast Agents Forecasted Market Size by Country 44
5.2.1 North America MRI Contrast Agents Sales in Volume by Country (2023-2028) 44
5.2.2 North America MRI Contrast Agents Sales in Value by Country (2023-2028) 44
6 Europe MRI Contrast Agents by Country 46
6.1 Europe MRI Contrast Agents Historic Market Size by Country 46
6.1.1 Europe MRI Contrast Agents Sales in Volume by Country (2017-2022) 46
6.1.2 Europe MRI Contrast Agents Sales in Value by Country (2017-2022) 47
6.2 Europe MRI Contrast Agents Forecasted Market Size by Country 47
6.2.1 Europe MRI Contrast Agents Sales in Volume by Country (2023-2028) 47
6.2.2 Europe MRI Contrast Agents Sales in Value by Country (2023-2028) 48
7 Asia-Pacific MRI Contrast Agents by Region 50
7.1 Asia-Pacific MRI Contrast Agents Historic Market Size by Region 50
7.1.1 Asia-Pacific MRI Contrast Agents Sales in Volume by Region (2017-2022) 50
7.1.2 Asia-Pacific MRI Contrast Agents Sales in Value by Region (2017-2022) 51
7.2 Asia-Pacific MRI Contrast Agents Forecasted Market Size by Region 52
7.2.1 Asia-Pacific MRI Contrast Agents Sales in Volume by Region (2023-2028) 52
7.2.2 Asia-Pacific MRI Contrast Agents Sales in Value by Region (2023-2028) 53
8 Latin America MRI Contrast Agents by Country 54
8.1 Latin America MRI Contrast Agents Historic Market Size by Country 54
8.1.1 Latin America MRI Contrast Agents Sales in Volume by Country (2017-2022) 54
8.1.2 Latin America MRI Contrast Agents Sales in Value by Country (2017-2022) 54
8.2 Latin America MRI Contrast Agents Forecasted Market Size by Country 55
8.2.1 Latin America MRI Contrast Agents Sales in Volume by Country (2023-2028) 55
8.2.2 Latin America MRI Contrast Agents Sales in Value by Country (2023-2028) 56
9 Middle East and Africa MRI Contrast Agents by Country 57
9.1 Middle East and Africa MRI Contrast Agents Historic Market Size by Country 57
9.1.1 Middle East and Africa MRI Contrast Agents Sales in Volume by Country (2017-2022) 57
9.1.2 Middle East and Africa MRI Contrast Agents Sales in Value by Country (2017-2022) 57
9.2 Middle East and Africa MRI Contrast Agents Forecasted Market Size by Country 58
9.2.1 Middle East and Africa MRI Contrast Agents Sales in Volume by Country (2023-2028) 58
9.2.2 Middle East and Africa MRI Contrast Agents Sales in Value by Country (2023-2028) 59
10 Company Profiles and Key Figures in MRI Contrast Agents Business 60
10.1 Bayer 60
10.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 60
10.1.2 MRI Contrast Agents Product Overview 61
10.1.3 Bayer MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 62
10.1.4 Main Business/Business Overview 63
10.2 Guerbet Group 63
10.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 63
10.2.2 MRI Contrast Agents Product Overview 64
10.2.3 Guerbet Group MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 64
10.2.4 Main Business/Business Overview 65
10.3 Bracco Imaging 65
10.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 65
10.3.2 MRI Contrast Agents Product Overview 66
10.3.3 Bracco Imaging MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 67
10.3.4 Main Business/Business Overview 68
10.4 GE Healthcare 68
10.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 68
10.4.2 MRI Contrast Agents Product Overview 69
10.4.3 GE Healthcare MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 69
10.4.4 Main Business/Business Overview 70
10.5 BeiLu Pharma 70
10.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 70
10.5.2 MRI Contrast Agents Product Overview 71
10.5.3 BeiLu Pharma MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 72
10.5.4 Main Business/Business Overview 72
10.6 Hengrui Medicine 72
10.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 72
10.6.2 MRI Contrast Agents Product Overview 73
10.6.3 Hengrui Medicine MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 73
10.6.4 Main Business/Business Overview 74
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 75
11.1 MRI Contrast Agents Key Raw Materials 75
11.1.1 Key Raw Materials 75
11.1.2 Raw Materials Key Suppliers 75
11.2 Manufacturing Cost Structure 76
11.2.1 Raw Materials 76
11.2.2 Labor Cost 76
11.2.3 Manufacturing Expenses 76
11.3 MRI Contrast Agents Industrial Chain Analysis 77
11.4 MRI Contrast Agents Market Dynamics 77
11.4.1 MRI Contrast Agents Industry Trends 77
11.4.2 MRI Contrast Agents Market Drivers 78
11.4.3 MRI Contrast Agents Market Challenges 78
11.4.4 Porter's Five Forces Analysis 78
12 Marketing Strategy Analysis, Distributors 80
12.1 Sales Channel 80
12.2 MRI Contrast Agents Distributors 81
12.3 MRI Contrast Agents Downstream Customers 82
13 Research Findings and Conclusion 84
14 Appendix 85
14.1 Research Methodology 85
14.1.1 Methodology/Research Approach 85
14.1.2 Data Source 88
14.2 Author Details 91
14.3 Disclaimer 91

 

ページTOPに戻る


 

Summary

Market Analysis and Insights: Global MRI Contrast Agents Market
Due to the COVID-19 pandemic, the global MRI Contrast Agents market size is estimated to be worth US$ 1384.86 million in 2021 and is forecast to a readjusted size of US$ 2110.73 million by 2028 with a CAGR of 5.87% during the review period.
The global main manufacturers of MRI Contrast Agents include Bayer, Guerbet Group, Bracco Imaging, GE Healthcare, BeiLu Pharma, Hengrui Medicine, and etc. In 2021, the global six largest players have a share approximately 94.07% in terms of revenue.
The North America MRI Contrast Agents market is estimated at US$ 462.57 million in 2021, while China is forecast to reach US$ 489.74 million by 2028. The proportion of the China is 17.77% in 2021 and it is predicted that the share will reach 23.20% in 2028, trailing a CAGR of 9.65% through the analysis period. As for the Europe MRI Contrast Agents landscape, Germany is projected to reach US$ 136.01 million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is 4.68% and 6.63% respectively for the next 6-year period.
Gadoterate Meglumine accounting for 27.37% of the MRI Contrast Agents global market in 2021, is projected to value US$ 563.17 million by 2028, growing at a revised 5.49% CAGR in the post-COVID-19 period. While Hospitals segment is altered to an 7.44% CAGR throughout this forecast period and will hold a share about 85.00% in 2028.
Global MRI Contrast Agents Scope and Market Size
The global MRI Contrast Agents market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global MRI Contrast Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
By Company
Bayer
Guerbet Group
Bracco Imaging
GE Healthcare
BeiLu Pharma
Hengrui Medicine

Segment by Type
Gadobutrol
Gadoterate Meglumine
Gadobenate Dimeglumine
Gadopentetate Dimeglumine
Gadoteridol
Gadodiamine
Others

Segment by Application
Hospitals
Clinics

By Region
North America
United States
Canada

Asia-Pacific
China
Japan
Korea
India
Taiwan
Southeast Asia
Australia

Europe
Germany
France
U.K.
Italy
Russia

Latin America
Mexico
Brazil
Argentina

Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 MRI Contrast Agents Market Overview 1
1.1 MRI Contrast Agents Product Overview 1
1.2 MRI Contrast Agents Market Segment by Type 3
1.2.1 Gadobutrol 3
1.2.2 Gadoterate Meglumine 5
1.2.3 Gadobenate Dimeglumine 6
1.2.4 Gadopentetate Dimeglumine 7
1.2.5 Gadoteridol 8
1.2.6 Gadodiamine 9
1.2.7 Others 10
1.3 Global MRI Contrast Agents Market Size by Type 11
1.3.1 Global MRI Contrast Agents Market Size Overview by Type (2017-2028) 11
1.3.2 Global MRI Contrast Agents Historic Market Size Review by Type (2017-2022) 12
1.3.3 Global MRI Contrast Agents Forecasted Market Size by Type (2023-2028) 14
1.4 Key Regions Market Size Segment by Type 17
1.4.1 North America MRI Contrast Agents Sales Breakdown by Type (2017-2022) 17
1.4.2 Europe MRI Contrast Agents Sales Breakdown by Type (2017-2022) 18
1.4.3 Asia-Pacific MRI Contrast Agents Sales Breakdown by Type (2017-2022) 19
1.4.4 Latin America MRI Contrast Agents Sales Breakdown by Type (2017-2022) 20
1.4.5 Middle East and Africa MRI Contrast Agents Sales Breakdown by Type (2017-2022) 21
2 MRI Contrast Agents Market Competition by Company 22
2.1 Global Top Players by MRI Contrast Agents Sales (2019-2022) 22
2.2 Global Top Players by MRI Contrast Agents Revenue (2019-2022) 23
2.3 Global Top Players by MRI Contrast Agents Price (2019-2022) 24
2.4 Global Top Manufacturers MRI Contrast Agents Manufacturing Base Distribution, Sales Area 25
2.5 MRI Contrast Agents Market Competitive Situation and Trends 25
2.5.1 MRI Contrast Agents Market Concentration Rate (2019-2022) 25
2.5.2 Global 3 and 5 Largest Manufacturers by MRI Contrast Agents Revenue in 2021 26
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRI Contrast Agents as of 2021) 26
2.7 Established Date of Key MRI Contrast Agents Manufacturers 27
2.8 Key Manufacturers MRI Contrast Agents Product Offered 28
2.9 Mergers & Acquisitions, Expansion 28
3 MRI Contrast Agents Status and Outlook by Region 29
3.1 Global MRI Contrast Agents Market Size and CAGR by Region: 2017 VS 2021 VS 2028 29
3.2 Global MRI Contrast Agents Historic Market Size by Region 29
3.2.1 Global MRI Contrast Agents Sales in Volume by Region (2019-2022) 29
3.2.2 Global MRI Contrast Agents Sales in Value by Region (2017-2022) 30
3.2.3 Global MRI Contrast Agents Sales (Volume & Value), Price and Gross Margin (2017-2022) 31
3.3 Global MRI Contrast Agents Forecasted Market Size by Region 31
3.3.1 Global MRI Contrast Agents Sales in Volume by Region (2023-2028) 31
3.3.2 Global MRI Contrast Agents Sales in Value by Region (2023-2028) 32
3.3.3 Global MRI Contrast Agents Sales (Volume & Value), Price and Gross Margin (2023-2028) 32
4 MRI Contrast Agents by Application 33
4.1 MRI Contrast Agents Market Segment by Application 33
4.1.1 Hospitals 33
4.1.2 Clinics 34
4.2 Global MRI Contrast Agents Market Size by Application 35
4.2.1 Global MRI Contrast Agents Market Size Overview by Application (2017-2028) 35
4.2.2 Global MRI Contrast Agents Historic Market Size Review by Application (2017-2022) 36
4.2.3 Global MRI Contrast Agents Forecasted Market Size by Application (2023-2028) 37
4.3 Key Regions Market Size Segment by Application 37
4.3.1 North America MRI Contrast Agents Sales Breakdown by Application (2017-2022) 37
4.3.2 Europe MRI Contrast Agents Sales Breakdown by Application (2017-2022) 38
4.3.3 Asia-Pacific MRI Contrast Agents Sales Breakdown by Application (2017-2022) 39
4.3.4 Latin America MRI Contrast Agents Sales Breakdown by Application (2017-2022) 40
4.3.5 Middle East and Africa MRI Contrast Agents Sales Breakdown by Application (2017-2022) 41
5 North America MRI Contrast Agents by Country 43
5.1 North America MRI Contrast Agents Historic Market Size by Country 43
5.1.1 North America MRI Contrast Agents Sales in Volume by Country (2017-2022) 43
5.1.2 North America MRI Contrast Agents Sales in Value by Country (2017-2022) 43
5.2 North America MRI Contrast Agents Forecasted Market Size by Country 44
5.2.1 North America MRI Contrast Agents Sales in Volume by Country (2023-2028) 44
5.2.2 North America MRI Contrast Agents Sales in Value by Country (2023-2028) 44
6 Europe MRI Contrast Agents by Country 46
6.1 Europe MRI Contrast Agents Historic Market Size by Country 46
6.1.1 Europe MRI Contrast Agents Sales in Volume by Country (2017-2022) 46
6.1.2 Europe MRI Contrast Agents Sales in Value by Country (2017-2022) 47
6.2 Europe MRI Contrast Agents Forecasted Market Size by Country 47
6.2.1 Europe MRI Contrast Agents Sales in Volume by Country (2023-2028) 47
6.2.2 Europe MRI Contrast Agents Sales in Value by Country (2023-2028) 48
7 Asia-Pacific MRI Contrast Agents by Region 50
7.1 Asia-Pacific MRI Contrast Agents Historic Market Size by Region 50
7.1.1 Asia-Pacific MRI Contrast Agents Sales in Volume by Region (2017-2022) 50
7.1.2 Asia-Pacific MRI Contrast Agents Sales in Value by Region (2017-2022) 51
7.2 Asia-Pacific MRI Contrast Agents Forecasted Market Size by Region 52
7.2.1 Asia-Pacific MRI Contrast Agents Sales in Volume by Region (2023-2028) 52
7.2.2 Asia-Pacific MRI Contrast Agents Sales in Value by Region (2023-2028) 53
8 Latin America MRI Contrast Agents by Country 54
8.1 Latin America MRI Contrast Agents Historic Market Size by Country 54
8.1.1 Latin America MRI Contrast Agents Sales in Volume by Country (2017-2022) 54
8.1.2 Latin America MRI Contrast Agents Sales in Value by Country (2017-2022) 54
8.2 Latin America MRI Contrast Agents Forecasted Market Size by Country 55
8.2.1 Latin America MRI Contrast Agents Sales in Volume by Country (2023-2028) 55
8.2.2 Latin America MRI Contrast Agents Sales in Value by Country (2023-2028) 56
9 Middle East and Africa MRI Contrast Agents by Country 57
9.1 Middle East and Africa MRI Contrast Agents Historic Market Size by Country 57
9.1.1 Middle East and Africa MRI Contrast Agents Sales in Volume by Country (2017-2022) 57
9.1.2 Middle East and Africa MRI Contrast Agents Sales in Value by Country (2017-2022) 57
9.2 Middle East and Africa MRI Contrast Agents Forecasted Market Size by Country 58
9.2.1 Middle East and Africa MRI Contrast Agents Sales in Volume by Country (2023-2028) 58
9.2.2 Middle East and Africa MRI Contrast Agents Sales in Value by Country (2023-2028) 59
10 Company Profiles and Key Figures in MRI Contrast Agents Business 60
10.1 Bayer 60
10.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 60
10.1.2 MRI Contrast Agents Product Overview 61
10.1.3 Bayer MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 62
10.1.4 Main Business/Business Overview 63
10.2 Guerbet Group 63
10.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 63
10.2.2 MRI Contrast Agents Product Overview 64
10.2.3 Guerbet Group MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 64
10.2.4 Main Business/Business Overview 65
10.3 Bracco Imaging 65
10.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 65
10.3.2 MRI Contrast Agents Product Overview 66
10.3.3 Bracco Imaging MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 67
10.3.4 Main Business/Business Overview 68
10.4 GE Healthcare 68
10.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 68
10.4.2 MRI Contrast Agents Product Overview 69
10.4.3 GE Healthcare MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 69
10.4.4 Main Business/Business Overview 70
10.5 BeiLu Pharma 70
10.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 70
10.5.2 MRI Contrast Agents Product Overview 71
10.5.3 BeiLu Pharma MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 72
10.5.4 Main Business/Business Overview 72
10.6 Hengrui Medicine 72
10.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 72
10.6.2 MRI Contrast Agents Product Overview 73
10.6.3 Hengrui Medicine MRI Contrast Agents Sales (L), Revenue (Million USD), Price (US$/mL) and Gross Margin (%) (2019-2022) 73
10.6.4 Main Business/Business Overview 74
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 75
11.1 MRI Contrast Agents Key Raw Materials 75
11.1.1 Key Raw Materials 75
11.1.2 Raw Materials Key Suppliers 75
11.2 Manufacturing Cost Structure 76
11.2.1 Raw Materials 76
11.2.2 Labor Cost 76
11.2.3 Manufacturing Expenses 76
11.3 MRI Contrast Agents Industrial Chain Analysis 77
11.4 MRI Contrast Agents Market Dynamics 77
11.4.1 MRI Contrast Agents Industry Trends 77
11.4.2 MRI Contrast Agents Market Drivers 78
11.4.3 MRI Contrast Agents Market Challenges 78
11.4.4 Porter's Five Forces Analysis 78
12 Marketing Strategy Analysis, Distributors 80
12.1 Sales Channel 80
12.2 MRI Contrast Agents Distributors 81
12.3 MRI Contrast Agents Downstream Customers 82
13 Research Findings and Conclusion 84
14 Appendix 85
14.1 Research Methodology 85
14.1.1 Methodology/Research Approach 85
14.1.2 Data Source 88
14.2 Author Details 91
14.3 Disclaimer 91

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(薬学的薬物)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る